| Code | 0257C | ||||||||||
| MA number | 44/0290/16-S | ||||||||||
| Product Form: | tbl 30x20 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 27.06.2016 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Zitazonium 20 mg_07.2022.pdf
|
| PIL: |
PIL_Zitazonium 20 mg_07.2022.pdf
|
| Safety feature | Yes |
| Data update: | 19.02.2021 |
